RFA-NS-25-025: Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Funding Organization: National Institutes of Health (NIH)
Total funding amount: $3,000,000
Maximum budget per application: $275,000
Project duration: 2 years
To support exploratory/developmental studies aimed at understanding, preventing, or treating GBS and CIDP.
Researchers in the field of neurology and autoimmune diseases.
Patients affected by GBS and CIDP.
Funding source: National Institute of Neurological Disorders and Stroke (NINDS)
Funding type: Grant (R21 Exploratory/Developmental Research Grant)
This is a new funding opportunity.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations
Small Businesses
Local, State, County, City or Township Governments
Indian/Native American Tribal Governments (both Federally Recognized and not)
Federal Government Agencies
U.S. Territories or Possessions
Independent School Districts
Public Housing Authorities/Indian Housing Authorities
Faith-based or Community-based Organizations
Regional Organizations
Foreign Organizations
Applicant organizations must complete registrations with SAM, eRA Commons, and Grants.gov.
Not specified
Understanding mechanisms of GBS and CIDP.
Identifying therapeutic targets and biomarkers.
Innovative studies on disease mechanisms, susceptibility factors, and treatments.
Research expertise in neurology and autoimmune diseases.
Combined budget for direct costs may not exceed $275,000.
No more than $200,000 may be requested in any single year.
No cost sharing is required.
Application due date: October 3, 2025.
Must comply with NIH Grants Policy Statement.
Follow the instructions in the How to Apply - Application Guide.